120(3):713-9.ĭauvilliers Y, Abril B, Mas E, Michel F, Tafti M. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. 12(2):95-107.Ĭvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, Dauvilliers Y, et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Kanbayashi T, Kodama T, Kondo H, Satoh S, Inoue Y, Chiba S. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. 32(8):993-8.īlouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Reduced number of hypocretin neurons in human narcolepsy. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. Review of rapid eye movement behavior sleep disorders.
AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, Olsén P, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al.
Abnormal sleep/wake dynamics in orexin knockout mice. 98(4):437-51.ĭiniz Behn CG, Klerman EB, Mochizuki T, Lin SC, Scammell TE. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. 98(3):365-76.Ĭhemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Narcolepsy: neural mechanisms of sleepiness and cataplexy. Narcolepsy: Pathophysiology and neuropsychological changes. Darien, IL: American Academy of Sleep Medicine. International Classification of Sleep Disorders. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Rochester, MN: American Academy of Sleep Medicine 2014. The International Classification of Sleep Disorders-Revised: Diagnostic and Coding Manual. 372-78.Īmerican Academy of Sleep Medicine. Arlington, VA: American Psychiatric Association 2013.
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Plymouth Meeting, PA: Harmony Biosciences, LLC. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, et al. Effective treatment of narcolepsy with codeine in a patient receiving hemodialysis. A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KK, et al. Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: a case-control study. Palaia V, Poli F, Pizza F, Antelmi E, Franceschini C, Moghadam KK, et al. Nocturnal aspects of narcolepsy with cataplexy. Narcolepsy in children: a single-center clinical experience. Vendrame M, Havaligi N, Matadeen-Ali C, Adams R, Kothare SV.